AJANTA PHARMA Announces Quarterly Results (2QFY20); Net Profit Down 7.2%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA Announces Quarterly Results (2QFY20); Net Profit Down 7.2%
Fri, 8 Nov

AJANTA PHARMA has announced its results for the quarter ended September 2019. Here is a detailed performance review of the same:

AJANTA PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Sep-18*
3
Jun-19*
3
Sep-19*
QoQ ChangeYoY Change
Net SalesRs m5,4416,1196,4285.0%18.1%
Other incomeRs m1527613273.0%-13.3%
TurnoverRs m5,5946,1966,5605.9%17.3%
ExpensesRs m3,7794,4364,6514.9%23.1%
Gross profitRs m1,6621,6841,7664.9%6.2%
DepreciationRs m1752282332.3%33.2%
InterestRs m11849175.4%3692.3%
Profit before taxRs m1,6381,5151,6166.7%-1.4%
TaxRs m38536845222.8%17.6%
Profit after taxRs m1,2541,1461,1641.5%-7.2%
Gross profit margin%30.527.527.5
Effective tax rate%23.524.328.0
Net profit margin%22.418.517.7
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 18.1% on a year-on-year (YoY) basis. The expenses were up by 23.1% YoY during the same period.
  • The company's operating profit increased by 6.2% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 27.5% in 2QFY20 as against 30.5% in 2QFY19.
  • Depreciation charges increased by 33.2% and finance costs increased by 3692.3% YoY, respectively.
  • Other income declined by 13.3% YoY during the quarter.
  • Net profit for the quarter declined by 7.2% YoY. Net profit margins during the quarter declined from 22.4% in 2QFY19 to 17.7% in 2QFY20.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 5.0% on a quarter-on-quarter (QoQ) basis. The expenses were up by 4.9% QoQ during the same period.
  • The company's operating profit increased by 4.9% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 27.5% in 2QFY20 as against 27.5% in 1QFY19.
  • Net profit for the quarter increased by 1.5% QoQ, while net profit margins declined from 18.5% in 1QFY19 to 17.7% in 2QFY20.

To see how AJANTA PHARMA has performed over the last eight quarters,please visit here.

Listen In: Our Investor Hour Podcast Connects You with the World's Most Successful Investors

AJANTA PHARMA Share Price Performance

Over the last one year,AJANTA PHARMA share price has moved down from Rs 1,058.0 to Rs 996.0, registering a Loss of Rs 62.0 or around 5.9%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,228.6 (down 0.7%). Over the last one year it has moved down from 14,540.6 to 13,228.6, a gain of 1,312 points (down 9.0%).

Overall, the S&P BSE SENSEX is up 15.1% over the year.

Current Valuations

At the current price of Rs 996.0, the price to earnings (P/E) ratio of AJANTA PHARMA stands at 22.6 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 3.9 times.

Equitymaster requests your view! Post a comment on "AJANTA PHARMA Announces Quarterly Results (2QFY20); Net Profit Down 7.2%". Click here!

  

Related Views on News

AJANTA PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 8.4% (Quarterly Result Update)

Aug 2, 2019 | Updated on Aug 2, 2019

For the quarter ended June 2019, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 8.4% YoY). Sales on the other hand came in at Rs 6 bn (up 19.8% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of AJANTA PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AJANTA PHARMA. Also includes updates on the valuation of AJANTA PHARMA.

AJANTA PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 5.9% (Quarterly Result Update)

May 3, 2019 | Updated on May 3, 2019

For the quarter ended March 2019, AJANTA PHARMA has posted a net profit of Rs 889 m (down 5.9% YoY). Sales on the other hand came in at Rs 5 bn (down 2.9% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

A Simple, 7-Step Checklist for Your Trading Success

Dec 4, 2019

What we can learn from one of the greatest traders to have ever lived.

Use My Secret to Increase Your Trading Profits Today

Dec 10, 2019

What to do after every trade.

Growth Stocks or Value Stocks... What Will Make You More Money in this Bull Market?(Profit Hunter)

Nov 28, 2019

Should you invest in growth stocks or value stocks to make strong returns in this market?

Blue Chips Are Passe. Get into these Stocks for Outstanding Gains in 2020(Profit Hunter)

Dec 5, 2019

This corner of the market could provide more returns than blue chips in 2020.

What Is the IPO Euphoria Signaling Us About the Markets?(The 5 Minute Wrapup)

Dec 2, 2019

2019 will be remembered as the year of great money-making IPOs...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

AJANTA PHARMA SHARE PRICE


Dec 11, 2019 (Close)

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AJANTA PHARMA 5-YR ANALYSIS

COMPARE AJANTA PHARMA WITH

MARKET STATS